🇺🇸 FDA

Drug profile · INN

radium ra-223 dichloride

XOFIGO

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

radium ra-223 dichloride (XOFIGO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN radium ra-223 dichloride
Brand XOFIGO
Route INTRAVENOUS
Formulation SOLUTION

Frequently asked questions

What is radium ra-223 dichloride?

radium ra-223 dichloride (XOFIGO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for radium ra-223 dichloride?

XOFIGO is a marketed brand name for radium ra-223 dichloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of radium ra-223 dichloride?

radium ra-223 dichloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.